Showing results (121-130 of 138) with videos related to
Sort By:
Pageof 14
Bioorganic & Medicinal Chemistry Letters|July 9, 2019
Synthesis and evaluation of tetrahydropyrazolopyridine inhibitors of anion exchange protein SLC26A4 (pendrin)Jie S Zhu, Julia Y Lu, Joseph-Anthony Tan, et al.Journal of Autoimmunity|August 1, 2006
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosisRoman Rieger, Patrick S C Leung, Melissa R Jeddeloh, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversibleKatsushi Amano, Patrick S C Leung, Qingchai Xu, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 16, 2018
Combination potentiator ('co-potentiator') therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiatorsPuay-Wah Phuan, Jung-Ho Son, Joseph-Anthony Tan, et al.Hepatology (Baltimore, Md.)|October 28, 2003
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacteriumCarlo Selmi, David L Balkwill, Pietro Invernizzi, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2013
Antimitochondrial antibody recognition and structural integrity of the inner lipoyl domain of the E2 subunit of pyruvate dehydrogenase complexJinjun Wang, Madhu S Budamagunta, John C Voss, et al.Molecular Pharmacology|February 22, 2005
Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gatingNicoletta Pedemonte, N D Sonawane, Alessandro Taddei, et al.Journal of Medicinal Chemistry|July 26, 2014
Constrained bithiazoles: small molecule correctors of defective ΔF508-CFTR protein traffickingKeith C Coffman, Huy H Nguyen, Puay-Wah Phuan, et al.Hepatology (Baltimore, Md.)|January 19, 2017
The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitisZongwen Shuai, Jinjun Wang, Madhu Badamagunta, et al.Bioorganic & Medicinal Chemistry|August 21, 2003
Benzoflavone activators of the cystic fibrosis transmembrane conductance regulator: towards a pharmacophore model for the nucleotide-binding domainMark F Springsteel, Luis J V Galietta, Tonghui Ma, et al.Pageof 14